GSK vs. WBA
Compare and contrast key facts about GlaxoSmithKline plc (GSK) and Walgreens Boots Alliance, Inc. (WBA).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: GSK or WBA.
Correlation
The correlation between GSK and WBA is 0.26, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
GSK vs. WBA - Performance Comparison
Key characteristics
GSK:
-0.11
WBA:
-0.58
GSK:
0.01
WBA:
-0.64
GSK:
1.00
WBA:
0.92
GSK:
-0.10
WBA:
-0.42
GSK:
-0.19
WBA:
-0.93
GSK:
15.39%
WBA:
39.69%
GSK:
24.92%
WBA:
63.47%
GSK:
-55.21%
WBA:
-87.93%
GSK:
-12.05%
WBA:
-83.33%
Fundamentals
GSK:
$79.23B
WBA:
$9.56B
GSK:
$1.61
WBA:
-$10.24
GSK:
0.39
WBA:
3.55
GSK:
$24.01B
WBA:
$113.36B
GSK:
$16.98B
WBA:
$19.49B
GSK:
$5.14B
WBA:
$490.00M
Returns By Period
In the year-to-date period, GSK achieves a 16.61% return, which is significantly lower than WBA's 18.54% return. Over the past 10 years, GSK has outperformed WBA with an annualized return of 2.96%, while WBA has yielded a comparatively lower -15.61% annualized return.
GSK
16.61%
1.51%
3.96%
-2.27%
5.22%
2.96%
WBA
18.54%
2.03%
31.44%
-36.05%
-18.78%
-15.61%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
GSK vs. WBA — Risk-Adjusted Performance Rank
GSK
WBA
GSK vs. WBA - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for GlaxoSmithKline plc (GSK) and Walgreens Boots Alliance, Inc. (WBA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
GSK vs. WBA - Dividend Comparison
GSK's dividend yield for the trailing twelve months is around 3.98%, less than WBA's 6.78% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GSK GlaxoSmithKline plc | 3.98% | 4.60% | 3.75% | 4.78% | 4.92% | 5.49% | 4.28% | 5.55% | 5.72% | 7.06% | 5.96% | 6.09% |
WBA Walgreens Boots Alliance, Inc. | 6.78% | 10.72% | 7.35% | 5.13% | 3.63% | 4.64% | 3.05% | 2.46% | 2.13% | 1.78% | 1.64% | 1.71% |
Drawdowns
GSK vs. WBA - Drawdown Comparison
The maximum GSK drawdown since its inception was -55.21%, smaller than the maximum WBA drawdown of -87.93%. Use the drawdown chart below to compare losses from any high point for GSK and WBA. For additional features, visit the drawdowns tool.
Volatility
GSK vs. WBA - Volatility Comparison
The current volatility for GlaxoSmithKline plc (GSK) is 6.83%, while Walgreens Boots Alliance, Inc. (WBA) has a volatility of 7.79%. This indicates that GSK experiences smaller price fluctuations and is considered to be less risky than WBA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
GSK vs. WBA - Financials Comparison
This section allows you to compare key financial metrics between GlaxoSmithKline plc and Walgreens Boots Alliance, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities